BANJA LUKA (Bosnia and Herzegovina), December 11 (SeeNews) – Serbia's largest drug maker Hemofarm, owned by Germany's STADA, has launched a second bid to buy the remaining 32.73% of Bosnian electronics manufacturer Cajavec it does not own yet at 0.5 marka($0.376/0.255 euro) per share.